Anatara Lifesciences Ltd (ANR) - Total Liabilities

Latest as of June 2025: AU$612.42K AUD ≈ $433.33K USD

Based on the latest financial reports, Anatara Lifesciences Ltd (ANR) has total liabilities worth AU$612.42K AUD (≈ $433.33K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check ANR asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Anatara Lifesciences Ltd - Total Liabilities Trend (2011–2025)

This chart illustrates how Anatara Lifesciences Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see ANR current and non-current assets.

Anatara Lifesciences Ltd Competitors by Total Liabilities

The table below lists competitors of Anatara Lifesciences Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Yangaroo Inc V:YOO	Canada	CA$3.79 Million
RBR Group Ltd AU:RBR	Australia	AU$2.16 Million
ETRUSCUS RESOURCES CORP. F:ERR	Germany	€189.69K
Universe Pharmaceuticals Inc NASDAQ:UPC	USA	$13.17 Million
Lazydays Holdings Inc NASDAQ:GORV	USA	$359.47 Million
Triangle Energy (Global) Ltd AU:TEG	Australia	AU$20.25 Million
Impax Asset Management Group Plc LSE:IPX	UK	GBX39.48 Million
Reinhold Europe AB WAR:RHD	Poland	zł2.15 Million

Liability Composition Analysis (2011–2025)

This chart breaks down Anatara Lifesciences Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of Anatara Lifesciences Ltd to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.89	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.14	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.53	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Anatara Lifesciences Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Anatara Lifesciences Ltd (2011–2025)

The table below shows the annual total liabilities of Anatara Lifesciences Ltd from 2011 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$612.42K ≈ $433.33K	+99.58%
2024-06-30	AU$306.85K ≈ $217.12K	-37.99%
2023-06-30	AU$494.83K ≈ $350.13K	+22.68%
2022-06-30	AU$403.35K ≈ $285.40K	-18.79%
2021-06-30	AU$496.67K ≈ $351.43K	+1.99%
2020-06-30	AU$486.96K ≈ $344.56K	+4.33%
2019-06-30	AU$466.76K ≈ $330.26K	-61.90%
2018-06-30	AU$1.22 Million ≈ $866.73K	+314.62%
2017-06-30	AU$295.44K ≈ $209.04K	-33.55%
2016-06-30	AU$444.62K ≈ $314.60K	+202.51%
2015-06-30	AU$146.98K ≈ $104.00K	-35.43%
2014-06-30	AU$227.62K ≈ $161.05K	-35.51%
2013-06-30	AU$352.96K ≈ $249.74K	+141.75%
2012-06-30	AU$146.00K ≈ $103.30K	+630.00%
2011-06-30	AU$20.00K ≈ $14.15K	--

About Anatara Lifesciences Ltd

AU:ANR Australia Biotechnology

Market Cap

$1.57 Million

AU$2.23 Million AUD

Market Cap Rank

#30338 Global

#1775 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.01 - AU$0.02

All Time High

AU$1.64